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INTRODUCTION:  In  endemic  goitre  areas,  20%  of the  population  over  70 will have  retrosternal  goitre.12
Obstructive  sleep  apnoea  (OSA)  occurs  when  there  are repeated  episodes  of complete  or partial  blockage
of  the  upper  airway  during  sleep.
PRESENTATION OF CASE:  A 55-year-old  man  was  being  treated  for  obstructive  sleep  apnoea,  came  with
stridor  worsening  over  the  2 and was  advised  CPAP  ventilation.  In our  institution,  he  was  diagnosed  to
have  goitre  with  retrosternal  extension  with  no  hypo/hyperthyroidism.  He  was  an obese  (BMI – 30 Kg/m2)
male  with  a  short,  broad neck  and  clinically  no  obvious  swelling  in  the  neck.  He  had  stridor,  with  pos-
itive  Kocher’s  test  as well  as Pemberton’s  sign.  His  TFT’s  were  normal  and  CT  scan  revealed  widening
of  superior  mediastinum.  Patient  was  pre-medicated  with  low  dose  (0.1 g)  fentanyl,  and  induced  with
inhalational  anaesthesia  (sevoﬂourane).  Endotracheal  intubation  was  done using  6 no.  ET  tube,  without
muscle  relaxation,  and  the  thyroid  was  removed  through  a  conventional  Kocher’s  incision.  Thyroid  was
enlarged  25  cm by 10 cm in  retrosternal  position.  Postoperatively,  pt  was  reversed  and shifted  to  ICU,  was
monitored  for  the  next 24  hours.  He was  extubated  uneventfully  the  next  morning.  Patient  had  a  good
post-op  recovery  and  was  discharged  on  the  7th  post-op  day.
DISCUSSION: Terms  such  as  retrosternal,  substernal,  intrathoracic,  or mediastinal  have  been  used  to
describe  a goitre  that extends  beyond  the  thoracic  inlet.  However,  there  is  a lack  of consensus  regarding
the  exact  deﬁnition  of a  retrosternal  goitre  (RSG).1 The  majority  of  patients  present  with  shortness  of
breath  or  asthma  like  symptoms  (68.8%),  as  was  the  case  in the studied  patient.  Other  modes  of  presen-
tation  include  neck  mass  (75%),  hoarseness  of voice  (37.5%),  dysphagia  (31.3%),  stridor/wheezing  (19%),
or  SVC  obstruction.  Upper airway  obstruction  due  to thyroid  gland  has  been  reported  up to  31%2 and
difﬁculty  in  intubation  has  been  reported  in  11%.3 Central  airway  obstruction  produces  symptoms  of
dyspnoea,  stridor,  or obstructive  pneumonia  and  is  often  misdiagnosed  as  asthma.4 The  CT scan  was  the
most  useful  tool  showing  the nature  and  extent  of  the lesion  in  the  reported  case.  In a recent  publication,
the  CT  scan  was  considered  the  gold-standard  preoperative  radiological  investigation.5 Surgery  is  the
only  effective  treatment  for retrosternal  goitres.  In most  cases,  suppressive  therapy  with  thyroxine  is
ineffective  in reducing  the size  of  multinodular  goitres;7,8 radio-iodine  therapy  is both  generally  ineffec-
tive  in large  goitres8 and  may  induce  acute  inﬂammation  and  swelling  of the  gland  with  the  potential  for
airway  obstruction.  The  operation  of choice  is  usually  a total  thyroidectomy.  Only  around  2%  of  patients
undergoing  thyroidectomy  for retrosternal  goitre  will require  surgical  access  other  than  a  standard  collar
incision  (either  manubriotomy,  sternotomy  or  thoracotomy).9
CONCLUSION:  Despite  all the  advances  in  investigative  modalities,  retrosternal  goitre  still  exists  in 20%
of  patients  over  70  years  in endemic  regions.  It has  to be  recognised  that  it can  be  a cause  of  obstructive
sleep  apnoea.  Early  detection  and  prompt  management  goes  a long  way  in decreasing  the  morbidity  and
mortality  in  patients  with  RSG.
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1. Introduction
As described by Candela in 2007, any goitre that descends below
the plane of the thoracic inlet or grows into the anterior medi-
Open access under CC BY-NC-ND license.astinum for more than 2 cm is considered retrosternal. In endemic
goitre areas, 20% of the population over 70 will have retroster-
nal goitre.12 Obstructive sleep apnoea (OSA) occurs when there
are repeated episodes of complete or partial blockage of the upper
ess under CC BY-NC-ND license. 
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Fig. 3. Gross specimen of thyroid.Fig. 1. Patient in pre-operative state.
irway during sleep. In this article, we present a patient with OSA
ho was subsequently found to have a retrosternal goitre.
. Case report
A 55-year-old diabetic and hypertensive man, being treated for
bstructive sleep apnoea, presented with stridor worsening over
he previous two years interfering in his daily life. His sleep was
isturbed due to sudden apnoea and a choking sensation at night,
tridor at rest and hoarseness. He was being treated with CPAP
entilation.
He was an elderly male, obese (BMI – 30 kg/m2) with a short,
road neck and clinically no obvious swelling in the neck. He had
tridor, with Kocher’s test and Pemberton’s sign positive. His thy-
oid function tests were within normal limits. His chest X-ray
howed widening of superior mediastinum.
On CT, there was a large exophytic well-deﬁned heteroge-
eously enhancing nodule arising from the lower pole of the right
obe of the thyroid gland with retrosternal extension measuring
.83 cm × 5.22 cm in max  dimensions and 7.55 cm in supero-
nferior extent, with a dystrophic calciﬁc focus in its lower portion,
ausing severe lateral compression of trachea with minimum
iameter of 0.38 cm at the site of compression with deviation
owards the left. Indirect laryngoscope examination was not pos-
ible as patient was severely breathless on attempting the same
Figs. 1–4).The patient was pre-medicated with low dose (0.1 g) fentanyl,
nd induced with inhalational anaesthesia (sevoﬂourane). Endo-
racheal intubation was  achieved with a number 6 endotracheal
ube, without muscle relaxation, which would have comprised the
Fig. 2. CT scan images – showing the rFig. 4. Microscopic view of the colloid adenomatous goitre.
airway resulting in disastrous consequences and was  mechani-
cally ventilated. The thyroid was  removed through a conventional
Kocher’s incision.
At surgery, the right lobe of thyroid was enlarged and nodular
measuring 15 cm × 10 cm with 10 cm × 10 cm retrosternal exten-
sion. The left lobe measured 15 cm × 8 cm,  and was nodular. Right
upper and left lower parathyroids and on the right side the recur-
rent laryngeal nerve was elongated and pushed downwards by the
retrosternal extension and was identiﬁed and preserved.
The patient was  extubated uneventfully the next morning. He
made a good post-operative recovery and was  discharged on the
seventh day. Histological examination conﬁrmed colloid adeno-
matous goitre. After a month the patient complained of insomnia
but had no symptoms of obstructive sleep apnea. He could now lie
down in supine position without any complaints. He required about
two months of Miloset (3 mg  HS) for his sleep rhythm to return to
normal.
etrosternal extent of the goitre.
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. Discussion
Terms such as retrosternal, substernal, intrathoracic, or medi-
stinal have been used to describe a goitre that extends beyond the
horacic inlet. However, there is a lack of consensus regarding the
xact deﬁnition of a retrosternal goitre (RSG).1 The signiﬁcant vari-
bility found in the literature regarding the clinical presentation
nd the surgical management of RSG can at least in some part, be
xplained by the different deﬁnitions employed.
The natural history of retrosternal goitre is of a slow relentless
ncrease in size, often presenting as an incidental ﬁnding on a chest
-ray in the ﬁfth or sixth decade of life. The most common symptom
s a feeling of pressure, due to the compression of the airway or great
eins in the neck.6
The majority of patients present with shortness of breath or
sthma like symptoms (68.8%) as was the case in the studied
atient. Other modes of presentation include neck mass (75%),
oarseness of voice (37.5%), dysphagia (31.3%), stridor/wheezing
19%), or SVC obstruction. Upper airway obstruction due to thyroid
land has been reported up to 31%2 and difﬁculty in intubation has
een reported in 11%.3 Central airway obstruction produces symp-
oms of dyspnoea, stridor, or obstructive pneumonia and is often
isdiagnosed as asthma.4
Thyrotoxic features are reported in less than 10% of RSG cases.2
he CT scan was the most useful tool showing the nature and extent
f the lesion in the reported case. In a recent publication, the CT
can was considered the gold-standard preoperative radiological
nvestigation.5
Prospective studies document the incidence of carcinoma devel-
pment in goitres at 1.3–3.7 new cases per 1000 patients.10,11
 recent review of evidence-based management of sub-sternal
oitres concluded that the incidence of malignant transformation
s equivalent in retrosternal goitres to those residing entirely in the
eck.9
Surgery is the only effective treatment for retrosternal goitres.
n most cases, suppressive therapy with thyroxine is ineffective
n reducing the size of multinodular goitres7,8; radio-iodine ther-
py is both generally ineffective in large goitres8 and may  induce
cute inﬂammation and swelling of the gland with the potential for
irway obstruction.
The operation of choice is usually a total thyroidectomy, elim-
nating the need for potential secondary surgery due to regrowth
f retained thyroid tissue. That said, on many occasions the ret-
osternal growth is often conﬁned to just one side of the thyroid
llowing the possibility of more limited surgery.1 Only around 2%
f patients undergoing thyroidectomy for retrosternal goitre will
equire surgical access other than a standard collar incision (either
anubriotomy, sternotomy or thoracotomy).9 The thyroid is usu-
lly removed through a conventional thyroid incision in the neck,
ut occasionally division of the upper part of the breast bone (ster-
um) is necessary, a procedure called a manubriotomy.5 For access
n which the cervical approach is not adequate, an intrathoracic
pproach should be employed including manubriotomy, full ster-
otomy and lateral thoracotomy.9
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4. Conclusion
The possibility of a retrosternal goitre should be borne in mind
when evaluating patients with breathing difﬁculties in goitre-
endemic areas.
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